Evidence map›Paper›PMID 27245359›Full record

ArticleRNA biology2016

Coupling between alternative polyadenylation and alternative splicing is limited to terminal introns.

Maliheh Movassat, Tara L Crabb, Anke Busch, Chengguo Yao, Derrick J Reynolds, Yongsheng Shi, Klemens J Hertel

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Transcription termination promotes splicing efficiency and fidelity in a compact genome.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Coupling of alternative splicing and alternative polyadenylation.Acta biochimica et biophysica Sinica · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Maliheh Movassata Department of Microbiology and Molecular Genetics , School of Medicine, University of California , Irvine , CA , USA.
Tara L Crabbb Institute of Molecular Biology (IMB) , Mainz , Germany.
Anke Buscha Department of Microbiology and Molecular Genetics , School of Medicine, University of California , Irvine , CA , USA.
Chengguo Yaoa Department of Microbiology and Molecular Genetics , School of Medicine, University of California , Irvine , CA , USA.
Derrick J Reynoldsa Department of Microbiology and Molecular Genetics , School of Medicine, University of California , Irvine , CA , USA.
Yongsheng Shia Department of Microbiology and Molecular Genetics , School of Medicine, University of California , Irvine , CA , USA.
Klemens J Hertela Department of Microbiology and Molecular Genetics , School of Medicine, University of California , Irvine , CA , USA.
University of California, Irvine · USInstitute of Molecular Biology · BG

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATIONR01GM062287 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HERTEL, KLEMENS J · 2001 to 2019
$4.8M
Characterization of the mammalian mRNA-3'-end processing complexR01GM090056 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SHI, YONGSHENG · 2010 to 2022
$4.2M
Coordinated regulation of alternative pre-mRNA processing in colon cancerR01CA177651 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDWARDS, ROBERT ANDREW, HERTEL, KLEMENS J · 2014 to 2018
$2.4M
NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA177651NIGMS NIH HHS R01 GM062287NIGMS NIH HHS R01 GM090056
6 · The paper itself

Abstract

Alternative polyadenylation has been implicated as an important regulator of gene expression. In some cases, alternative polyadenylation is known to couple with alternative splicing to influence last intron removal. However, it is unknown whether alternative polyadenylation events influence alternative splicing decisions at upstream exons. Knockdown of the polyadenylation factors CFIm25 or CstF64 in HeLa cells was used as an approach in identifying alternative polyadenylation and alternative splicing events on a genome-wide scale. Although hundreds of alternative splicing events were found to be differentially spliced in the knockdown of CstF64, genes associated with alternative polyadenylation did not exhibit an increased incidence of alternative splicing. These results demonstrate that the coupling between alternative polyadenylation and alternative splicing is usually limited to defining the last exon. The striking influence of CstF64 knockdown on alternative splicing can be explained through its effects on UTR selection of known splicing regulators such as hnRNP A2/B1, thereby indirectly influencing splice site selection. We conclude that changes in the expression of the polyadenylation factor CstF64 influences alternative splicing through indirect effects.

Indexed as

Alternative SplicingHeLa CellsHeterogeneous-Nuclear Ribonucleoprotein Group A-BHumansIntronsmRNA Cleavage and Polyadenylation FactorsPolyadenylationHeterogeneous-Nuclear Ribonucleoprotein Group A-BmRNA Cleavage and Polyadenylation FactorsAlternative polyadenylationalternative splicingCFIm25CstF64HnRNP A2/B1PAS-SeqRNA-Seq

Identifiers

PMID27245359
PMCPMC4962795
OpenAlexW2463869186

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.